Clin2
NCT07217353Possibly a fitEnrolling by invitation

Testing a new speculum for endometrial biopsies

Endometrial Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This trial tests a new type of vaginal speculum designed to make endometrial biopsies (a procedure to take a small sample of the lining of the uterus) more comfortable and effective. If you have had this biopsy before at the Minnesota Oncology Clinic, you may be eligible to help evaluate this new tool.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are a biological woman with a uterus.
  • You are between 18 and 90 years old.
  • You have had an endometrial biopsy before at the Minnesota Oncology Clinic.
  • You are not pregnant, do not have an active pelvic infection, and do not have uncontrolled bleeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04570553Recruiting
Testing a tool during surgery for early endometrial cancer

This study looks at how well a surgical tool is used during standard surgery for early endometrial cancer, and whether it relates to test results from fluid taken in the abdomen. It may help surgeons improve how samples are collected and interpreted during routine care.

York, Pennsylvania
NCT07148154Recruiting
Non-invasive test for endometrial cancer screening

This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.

L'Hospitalet de Llobregat, Barcelona
NCT06672341Not yet recruiting
Endometrial cytology and methylation testing for endometrial cancer screening

This study tests two less invasive methods—sampling cells from the lining of the uterus (endometrial cytology) and checking DNA changes in the cervix—to see if they can help detect endometrial cancer or atypical hyperplasia, and to monitor response in people who are preserving their fertility. It aims to find a gentler alternative to traditional biopsy.

NCT05051722Recruiting
Test DNA blood and tissue markers to detect gynecologic cancers

This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.

Phoenix, Arizona
NCT06501846Recruiting
Ultrasound-guided womb lining biopsy for postmenopausal bleeding

This trial tests a new way to take a small sample of the womb lining (biopsy) using a thin, flexible tube guided by ultrasound. The goal is to see if ultrasound guidance makes the biopsy more accurate and comfortable in people with post-menopausal bleeding.

London
NCT07429799Not yet recruiting
Detecting womb and ovarian cancers with a vaginal sample

This study tests a new device that collects a sample from the vagina to look for signs of womb (endometrial) or ovarian cancer. It may offer a simpler way to check for these cancers compared to current methods.

Hear when a new Endometrial Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.